^Minagawa N, Yabu Y, Kita K, Nagai K, Ohta N, Meguro K, et al. (February 1997). "An antibiotic, ascofuranone, specifically inhibits respiration and in vitro growth of long slender bloodstream forms of Trypanosoma brucei brucei". Molecular and Biochemical Parasitology. 84 (2): 271–280. doi:10.1016/S0166-6851(96)02797-1. PMID9084049.
^Yabu Y, Yoshida A, Suzuki T, Nihei C, Kawai K, Minagawa N, et al. (June 2003). "The efficacy of ascofuranone in a consecutive treatment on Trypanosoma brucei brucei in mice". Parasitology International. 52 (2): 155–164. doi:10.1016/S1383-5769(03)00012-6. PMID12798927.
^Magae J, Suzuki S, Nagai K, Yamasaki M, Ando K, Tamura G (March 1986). "In vitro effects of an antitumor antibiotic, ascofuranone, on the murine immune system". Cancer Research. 46 (3): 1073–1078. PMID3080231.